Back to AZN
Phase 3
Development Phase
2
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Competitive Landscape
0 competitors in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
View Full LandscapeDrug Information
Target Indication
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical Trial
NCT05057494Last updated: 1/2/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts